Literature DB >> 8105033

Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?

A S Freedman, L M Nadler.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8105033     DOI： 10.1200/JCO.1993.11.10.1841

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

2.  High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.

Authors:  Ulrich J M Mey; Vandana Jha; John W Strehl; Marcus Gorschlueter; Christian Rabe; Eckfried Hoebert; Henning Popp; Ingo G H Schmidt-Wolf
Journal:  Ger Med Sci       Date:  2007-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.